Search Results

Managing Difficult Aortic Necks

A perspective from a Chinese vascular program.

By Xiao Tang, MD; Weiguo Fu, MD; and Yuqi Wang, MD

Managing Difficult Aortic Necks

A perspective from a Chinese vascular program.

By Xiao Tang, MD; Weiguo Fu, MD; and Yuqi Wang, MD

Managing Difficult Aortic Necks

A perspective from a Chinese vascular program.

By Xiao Tang, MD; Weiguo Fu, MD; and Yuqi Wang, MD

The Future of Artificial Intelligence in Interventional Oncology

Potential applications of AI within IO include patient diagnosis, response prediction, and intraprocedural guidance, dependent upon standardized and responsible implementation.

By Helen Zhang, BS; Shreyas Kulkarni, BS; Zhicheng Jiao, PhD; and Harrison X. Bai, MD, MS

IVC Filter Use in 2018 and Beyond

Optimizing utility and retrieval to provide appropriate protection.

By Osman Ahmed, MD, and Vibhor Wadhwa, MD

Artificial Intelligence in Neurointerventions

A comprehensive review of AI technologies utilized in diagnosis and outcome prediction for ischemic stroke, intracranial aneurysms, and brain arteriovenous malformations.

By Rajeev D. Sen, MD, and Michael R. Levitt, MD

The Renal Stenting Debate

Is this procedure underused or overused? Yes.

By Thomas A. Sos, MD

Venous Arterialization for CLI: When, Why, and How?

Identifying appropriate patients and techniques for treating no-option CLI with percutaneous deep vein arterialization.

By Daniel A.F. van den Heuvel, MD; Michiel A. Schreve, MD; and Steven Kum, MD

Current Role and Future Needs of PAE in 2024: A Urologist’s Perspective

In light of its inclusion in recent American Urological Association guidelines, a group of urologists share a commentary on prostatic artery embolization and its efficacy, safety, and technical aspects, as well as future perspectives and the role of interdisciplinary collaboration.

By Alessandro Marquis, MD; Thomas R. Williams, MD; Timothy D. McClure, MD; and Ardeshir R. Rastinehad, DO

The True Prevalence of PAD and the Economics of Major Amputation

Mary L. Yost, MBA, presents an evidence-based approach to amputation, sharing her estimate of the current prevalence of peripheral artery disease, the impact of amputation on health care costs, and potential reimbursement changes.

Mentors and Protégés: Conversations on Career and Craft With Avnesh S. Thakor, MD, PhD, MB BChir, FHEA, FRCR(IR)

SIR physician trainee Yang (John) Qiao, MD, speaks with Dr. Thakor about his varied experience training as a physician, being a physician-scientist, the effort to create a new IR subspecialty called interventional regenerative medicine, and more.

Chronic Limb-Threatening Ischemia in the Era of AI

Improving patient care, current data, and the potential of artificial intelligence in CLTI treatment.

By Elsie Gyang Ross, MD, MSc

Advancements Across Interventional Oncology

By Yilun Koethe, MD, RPVI, and Ripal Gandhi, MD, FSIR, FSVM

Renal Ablation: Can We Push the Treatment Boundaries?

Strategies for treatment based on size criteria, ablation modality, tumor location, periprocedural considerations, and combination therapy options.

By Ronak Patel, BS, and Merve Ozen, MD

Creating CLI Teams

The VIVA Physicians' Vascular Leaders Forum offers guidance on core competencies and quality measures for establishing multidisciplinary CLI care teams.

By John H. Rundback, MD; Tony S. Das, MD; Peter A. Schneider, MD; and Michael R. Jaff, DO; on behalf of the VLF participants

Bead Technology: What’s New, What’s Next?

A review of mechanical properties and a discussion of available embolic particulates, recent advances for benign disease, novel concepts in the tumor microenvironment, and evolving use in liver cancer.

By Srinivasan Narayanan, MD, PhD; Andrea C. Cortes; and Rony Avritscher, MD